세계의 동물용 항감염제 시장은 2024년에 83억 7,000만 달러로 평가되었고, CAGR 6.45%를 나타낼 전망이며, 2030년에는 122억 달러에 이를 것으로 예측되고 있습니다.
세계의 동물용 항감염제 시장은 가축과 동반 동물의 개체수가 계속 증가하고 있으며 효과적인 질병 예방 및 치료 솔루션에 대한 수요가 높아짐에 따라 안정적인 성장을 이루고 있습니다. 항감염제는 동물의 건강을 유지하고 식품의 안전을 보장하며 동물 유래 단백질의 세계 공급을 지원하는 데 중요한 역할을 합니다. 동물의 세균성, 바이러스성, 진균성 감염이 증가하고 있기 때문에 축산과 동반 동물의 부문에서 고급 항감염제에 대한 강한 요구가 탄생하고 있습니다. 시기적절한 수의학의 중요성에 대한 농가와 반려동물 주인의 의식의 고조가 항생제, 항바이러스제, 항진균제, 병용요법의 채용을 더욱 가속화하고 있습니다. 식육, 우유, 계란 수요 증가에 대응하기 위한 상업적 축산의 확대가 질병 관리의 중요성을 높여 동물용 항감염제는 현대 동물 의료에 필수적인 요소가 되고 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 83억 7,000만 달러 |
| 시장 규모 : 2030년 | 122억 달러 |
| CAGR : 2025-2030년 | 6.45% |
| 급성장 부문 | 항바이러스제 |
| 최대 시장 | 북미 |
시장 성장 촉진요인은 인류 공통 감염의 발생률 증가를 포함하여 공중 보건을 보호하기 위해 동물의 감염 대책에 대한 관심이 높아지고 있습니다. 수의학 연구개발에 대한 투자 증가도 장시간 작용형 주사제, 표적 약물 전달 시스템, 내성 문제에 대처하는 병용 요법 등 항감염제 제제의 기술 혁신에 박차를 가하고 있습니다. 치료 비용을 절감하고 생산성을 향상시키는 건강 관리 방법으로 생산자와 주인이 이동하여 예방 솔루션에 대한 수요가 높아지고 있습니다. 시장을 형성하는 큰 동향은 항균제 내성에 대한 세계적인 우려를 반영하고, 프로바이오틱스, 피토제닉, 면역자극제 등 항생제의 대체품으로의 전환입니다. 또한 진단기술의 끊임없는 진보로 감염증의 신속한 발견이 가능해져 항감염제의 효과적인 사용을 보완하고 정밀한 수의학을 지원하고 있습니다.
시장은 향후 몇 년간의 가능성을 제한할 수 있는 과제에 직면하고 있습니다. 새로운 동물용 의약품의 개발 비용이 높고 규제 당국의 승인 프로세스가 엄격하기 때문에 제품의 상시가 지연되고 특정 지역에서의 입수가 제한되는 경우가 많습니다. 항균제 내성을 둘러싼 우려는 항생제의 사용 제한의 엄격화로 이어지고 있어, 제조업체는 대체품에 대한 투자를 강요받는 한편, 최종 사용자에게 있어서의 가격 감과의 밸런스를 취할 필요가 있습니다. 소규모 축산 농가에서는 항 감염의 올바른 사용법에 대한 인식이 낮기 때문에 오용이나 효능의 저하, 내성 위험의 증대가 발생할 수 있습니다. 또한 원격지와 과소지에서 공급망의 제약은 중요한 의약품에 대한 적시 접근을 제한합니다. 이러한 과제를 해결하기 위해서는 정부, 제약기업, 동물의료서비스 제산업체가 협력하여 인지도를 높이고 유통망을 강화하며 보다 안전하고 지속 가능한 항감염제 솔루션의 혁신을 가속화해야 합니다. 이러한 장애물에도 불구하고, 세계의 동물용 항감염제 시장은 동물 의료 요구 증가, 의료 관행의 진화, 동수처리의 지속적인 진보에 힘입어 확대될 것으로 예측됩니다.
가축·가금류에 있어서의 감염증의 발생률의 상승
항균제 내성(AMR)에 대한 우려 증가
처방전 기반 채널 및 디지털 판매 확대
Global Veterinary Anti-infectives Market was valued at USD 8.37 Billion in 2024 and is expected to reach USD 12.20 Billion by 2030 with a CAGR of 6.45%. The Global Veterinary Anti-infectives Market is experiencing steady growth as livestock and companion animal populations continue to rise, driving greater demand for effective disease prevention and treatment solutions. Anti-infectives play a critical role in maintaining animal health, ensuring food safety, and supporting the global supply of animal-based proteins. The increasing prevalence of bacterial, viral, and fungal infections in animals is creating a strong need for advanced anti-infective medicines across both livestock and companion animal sectors. Growing awareness among farmers and pet owners about the importance of timely veterinary care has further accelerated the adoption of antibiotics, antivirals, antifungals, and combination therapies. Expanding commercial livestock farming to meet the rising demand for meat, milk, and eggs has amplified the importance of disease control, positioning veterinary anti-infectives as an indispensable component of modern animal healthcare practices.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 8.37 Billion |
| Market Size 2030 | USD 12.20 Billion |
| CAGR 2025-2030 | 6.45% |
| Fastest Growing Segment | Antivirals |
| Largest Market | North America |
Growth drivers for the market include the rising incidence of zoonotic diseases, which has heightened the focus on controlling animal infections to safeguard public health. Increasing investments in veterinary research and development are also fueling innovation in anti-infective formulations, including long-acting injectables, targeted drug delivery systems, and combination therapies that address resistance issues. Demand for preventive solutions is gaining traction as producers and pet owners shift toward health management practices that reduce treatment costs and improve productivity. A major trend shaping the market is the transition toward antibiotic alternatives such as probiotics, phytogenics, and immunostimulants, reflecting global concerns about antimicrobial resistance. Continuous advancements in diagnostic technologies are also enabling faster detection of infections, which complements the effective use of anti-infectives and supports precision veterinary medicine.
The market faces challenges that could restrict its potential in the coming years. High development costs for new veterinary medicines, coupled with stringent regulatory approval processes, often delay product launches and limit accessibility in certain regions. Concerns around antimicrobial resistance are leading to stricter restrictions on antibiotic usage, pressuring manufacturers to invest in alternatives while balancing affordability for end users. Limited awareness among small-scale livestock farmers about the correct use of anti-infectives can result in misuse, reduced efficacy, and increased resistance risks. Supply chain limitations in remote or underdeveloped areas also restrict timely access to critical medicines. Addressing these challenges requires coordinated efforts between governments, pharmaceutical companies, and veterinary service providers to enhance awareness, strengthen distribution networks, and accelerate innovation in safer, sustainable anti-infective solutions. Despite these hurdles, the Global Veterinary Anti-infectives Market is expected to expand, supported by rising animal health needs, evolving healthcare practices, and ongoing advancements in veterinary therapeutics.
Key Market Drivers
Rising Incidence of Infectious Diseases in Livestock and Poultry
The rising incidence of infectious diseases in livestock and poultry is a significant driver of the Global Veterinary Anti-infectives Market. In the United States, the USDA reported processing over 9.4 billion broiler chickens and 218 million turkeys in 2023. This large-scale production increases the risk of disease outbreaks, necessitating effective anti-infective solutions to maintain animal health and productivity. Similarly, India, with the world's highest livestock population, including 300 million cattle and buffaloes and 851 million poultry, faces challenges in managing diseases among its vast animal population. The prevalence of diseases such as Foot and Mouth Disease and Lumpy Skin Disease in these regions underscores the need for robust veterinary anti-infective measures.
In China, the Ministry of Agriculture and Rural Affairs has been proactive in enhancing animal health surveillance and disease control programs to address the growing concerns of infectious diseases in livestock and poultry. The government's efforts to strengthen veterinary infrastructure and promote disease prevention strategies have contributed to the increased demand for veterinary anti-infectives. These initiatives aim to mitigate the impact of infectious diseases on animal health and ensure food security. The escalating incidence of infectious diseases in livestock and poultry across these regions highlights the critical need for effective veterinary anti-infectives to safeguard animal health and support the growth of the global veterinary anti-infectives market.
Key Market Challenges
Rising Concerns Over Antimicrobial Resistance (AMR)
Rising concerns over antimicrobial resistance (AMR) represent one of the most significant challenges for the Global Veterinary Anti-infectives Market, as the misuse and overuse of antibiotics in livestock and companion animals contribute to the development of drug-resistant pathogens. AMR poses serious threats not only to animal health but also to human health due to the potential transfer of resistant bacteria through the food chain, direct contact, or environmental contamination. Regulatory authorities worldwide are increasingly implementing stricter guidelines to limit antibiotic use in animals, including restrictions on growth-promoting antibiotics and tighter controls on prophylactic administration. These regulations create pressure on manufacturers and veterinarians to adopt alternative approaches to disease management, such as vaccines, immunostimulants, probiotics, and other non-antibiotic therapies, which may not always be as widely available or cost-effective as traditional anti-infectives.
The growing awareness of AMR among consumers, farmers, and healthcare professionals has intensified demand for responsible and judicious use of veterinary medicines. Pharmaceutical companies face the challenge of balancing the development of effective anti-infectives with compliance to evolving global standards while ensuring affordability for farmers, particularly in emerging markets where cost sensitivity is high. Research and development efforts to create next-generation therapies that are effective yet less prone to resistance are resource-intensive, requiring significant time and financial investment. Inadequate farmer education and poor adherence to dosing protocols can exacerbate resistance issues, further complicating disease management. The AMR challenge is reshaping treatment strategies and driving innovation in veterinary medicine, but it also imposes significant operational, regulatory, and economic pressures on the veterinary anti-infectives market, making it a critical hurdle for sustained growth and adoption.
Key Market Trends
Expansion of Prescription-Based Channels and Digital Sales
A key trend in the Global Veterinary Anti-infectives Market is the expansion of prescription-based channels and digital sales, which is reshaping how veterinary medicines are accessed and distributed. Increasing regulatory oversight on antimicrobial usage, aimed at combating antimicrobial resistance, has led many countries to restrict the availability of certain anti-infective drugs over the counter, prompting a shift toward prescription-only access. This transition ensures more controlled and responsible usage of antibiotics, antivirals, and antifungal medications, while improving adherence to dosage guidelines and reducing the risk of resistance development. Prescription-based channels also allow veterinarians to play a more active role in disease management, guiding producers and pet owners on the appropriate choice of therapy and monitoring treatment outcomes.
Simultaneously, digital sales platforms and e-commerce solutions are expanding the reach of veterinary anti-infectives to both urban and rural markets. Online pharmacies and veterinary supply platforms provide convenient access to a broad portfolio of medicines, particularly for farmers managing large herds or flocks where timely procurement is essential. Integration of digital tools with prescription channels enables better tracking of drug usage, inventory management, and compliance with veterinary guidelines. Telemedicine and virtual consultation services are also gaining traction, allowing veterinarians to diagnose, prescribe, and monitor treatments remotely, which is especially valuable in regions with limited veterinary infrastructure. The combination of stricter prescription regulations and the convenience of digital sales channels is transforming the market landscape, enhancing accessibility, supporting antibiotic stewardship programs, and encouraging data-driven decision-making in veterinary healthcare. This trend is expected to continue shaping the adoption and distribution of anti-infectives across livestock and companion animal segments globally.
In this report, the Global Veterinary Anti-infectives Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Anti-infectives Market.
Global Veterinary Anti-infectives Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: